The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Fennec Pharmaceuticals Inc(NASDAQ:FENC) 
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced heari...
Fennec Pharmaceuticals Days Payable Outstanding ttm (DPO)
Fennec Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Fennec Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Fennec Pharmaceuticals Op Cashflow Per Share ttm
Fennec Pharmaceuticals Free Cashflow Per Share ttm
Fennec Pharmaceuticals Cash Per Share ttm
Fennec Pharmaceuticals P/S ratio ttm
Fennec Pharmaceuticals (GAAP) P/E ratio ttm
Fennec Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.